Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06053255 · ClinicalTrials.gov registry record · NA
Use of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis
A NA study of Sacroiliitis, sponsored by FUSMobile.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06053255: Recruiting NA study of Sacroiliitis, sponsored by FUSMobile.
NCT06053255 is a NA study of Sacroiliitis that is actively recruiting participants, run by FUSMobile. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06053255, a NA study of Sacroiliitis, is actively recruiting participants, sponsored by FUSMobile.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The Neurolyser XR is a device used to deliver high-intensity focused ultrasound for the ablation of the lateral sacral branch nerve in patients with Sacroiliitis.
Primary Outcome
Per the CTCAE assessment, each organ or possible adverse event would be categorized on a scale of 1 to 5 where: Grade 1 is Mild; asymptomatic or mild symptoms; clinical or diagnostic observations only; intervention not indicated. Grade 2 is Moderate; minimal, local, or noninvasive intervention indicated; limiting age-appropriate instrumental Activities of Daily Living (ADL). Grade 3 is Severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hos
Conditions Studied
Interventions
- DEVICE High-intensity focused ultrasound for Sacroiliitis using the Neurolyser XR
Study Locations (1)
Virginia
- University of Virginia, Department of Anesthesiology - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-09-13 |
| Est. Completion | 2026-12-15 |
| Phase | NA |
What NCT06053255 shows while recruiting
NCT06053255 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Sacroiliitis appearing as the primary indexed condition, and to 1 intervention - of which High-intensity focused ultrasound for Sacroiliitis using the Neurolyser XR is the first listed.
NCT06053255 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06053255 about?
NCT06053255 is a clinical study titled "Use of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis". The Neurolyser XR is a device used to deliver high-intensity focused ultrasound for the ablation of the lateral sacral branch nerve in patients with Sacroiliitis.
What is the current status of trial NCT06053255?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-09-13. Estimated completion is 2026-12-15.
What conditions does trial NCT06053255 study?
This clinical trial studies the following conditions: Sacroiliitis.
What interventions are being tested in trial NCT06053255?
The interventions under investigation include: High-intensity focused ultrasound for Sacroiliitis using the Neurolyser XR (DEVICE).
Who is sponsoring clinical trial NCT06053255?
This trial is sponsored by FUSMobile, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06053255 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sacroiliitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06053255's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI